Apeiron Capital Investment Corp. Announces Termination of Business Combination Agreement and Liquidation BOSTON, MA , Aug. 11, 2023 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it has notified GIO World Health, Ltd. that the Company has elected to terminate...

GIO World Health Ltd, a Leading Stem Cell Life Science Company, Announces Plans to Go Public via Business Combination with Apeiron Capital Investment Corp. GIO World Health Ltd (“GIO World Health”) has entered into a business combination agreement with Apeiron Capital Investment Corp (APNC).The post-closing combined public company, which will be...

Apeiron Capital Investment Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 30, 2021 Boston, MA, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (NYSE: APN U) (the “Company”) announced today that, commencing December 30, 2021, holders of the units sold in the...

Apeiron Capital Investment Corp. Announces Closing of $172,500,000 Initial Public Offering Including the Full Exercise of the Over-Allotment Option Boston, Massachusetts, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it closed its initial public offering of 17,250,000 units, at $10.00...

Apeiron Capital Investment Corp. Announces Pricing of $150,000,000 Initial Public Offering Boston, Massachusetts, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it priced its initial public offering of 15,000,000 units, at $10.00...